Compare $ALLR vs $MRKR | Chartloom

Compare

$ALLR vs $MRKR

Allarity Therapeutics Inc · Marker Therapeutics Inc

ALLR

Allarity Therapeutics Inc

MRKR

Marker Therapeutics Inc

Compare $ALLR vs $MRKR

Comparing Allarity Therapeutics Inc and Marker Therapeutics Inc

ALLRAllarity Therapeutics Inc

MRKRMarker Therapeutics Inc

ALLRAllarity Therapeutics Inc

Market cap

$16M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-13.2%

52W performance

-41.8%

FCF yield

-87.5%

MRKRMarker Therapeutics Inc

Market cap

$16M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

3.16x

Rev growth (TTM)

-46.2%

YTD performance

-36.9%

52W performance

-10.0%

FCF yield

-60.2%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ALLR

MRKR

Detailed metrics comparison

ALLR

Allarity Therapeutics Inc

MRKR

Marker Therapeutics Inc

Market Cap

ALLR$16M

MRKR$16M

Enterprise Value

ALLR$21M

MRKR$5M

Price

ALLR$0.99

MRKR$0.97

P/E Ratio

ALLRN/A

MRKRN/A

P/S Ratio

ALLR45.65x

MRKR6.93x

EV/Sales

ALLR61.03x

MRKR2.08x

EV/EBITDA

ALLR0.00x

MRKR0.00x

P/B Ratio

ALLR4.68x

MRKR1.44x

P/FCF Ratio

ALLRN/A

MRKRN/A

EV/FCF

ALLR-1.53x

MRKR-0.50x

PEG Ratio

ALLRN/A

MRKRN/A

Forward P/E (NTM)

ALLRN/A

MRKRN/A

Forward P/S (NTM)

ALLRN/A

MRKR3.16x

Revenue (TTM)

ALLR$345K

MRKR$2M

Revenue Growth (YoY)

ALLRN/A

MRKR-46.2%

Forward Rev Growth

ALLR0.0%

MRKR375.8%

Gross Margin (TTM)

ALLR0.0%

MRKR0.0%

Operating Margin (TTM)

ALLR0.0%

MRKR0.0%

EBITDA Margin (TTM)

ALLR-771.9%

MRKR-284.3%

Net Margin (TTM)

ALLR-3575.1%

MRKR-236.6%

FCF Margin (TTM)

ALLR-3994.8%

MRKR-417.6%

Net Income (TTM)

ALLR$-12M

MRKR$-6M

FCF (TTM)

ALLR$-14M

MRKR$-10M

EPS (TTM)

ALLR-$0.78

MRKR-$0.27

ROE (TTM)

ALLR-15277.0%

MRKR-8086.0%

ROA (TTM)

ALLR-4650.0%

MRKR-6705.0%

ROIC (TTM)

ALLR-6256.0%

MRKR-8086.0%

Cash

ALLR$17M

MRKR$11M

Debt

ALLR$22M

MRKR$0

Net Cash/Debt

ALLR$-5M

MRKR$11M

Current Ratio (TTM)

ALLR1.11x

MRKR6.03x

Quick Ratio (TTM)

ALLR0.99x

MRKR5.60x

Debt/Equity (TTM)

ALLR6.30x

MRKR0.00x

Debt/Assets (TTM)

ALLR0.0%

MRKR0.0%

Interest Coverage (TTM)

ALLRN/A

MRKRN/A

Net Debt/EBITDA (TTM)

ALLR0.00x

MRKR0.00x

Beta

ALLR0.60

MRKR1.59

52W Performance

ALLR-41.8%

MRKR-10.0%

YTD Performance

ALLR-13.2%

MRKR-36.9%

% from 52W High

ALLR-46.2%

MRKR-60.5%

% from 52W Low

ALLR28.6%

MRKR15.7%

Asset Turnover (TTM)

ALLR0.00x

MRKR0.20x

FCF Yield (TTM)

ALLR-87.5%

MRKR-60.2%

Earnings Yield (TTM)

ALLR-78.3%

MRKR-34.1%

Dividend Yield (TTM)

ALLRN/A

MRKRN/A

Rule of 40

ALLR-3,994.8

MRKR-463.8

EV/GP/RG

ALLRN/A

MRKRN/A

Ticker research

View ALLR research View MRKR research

Metric	ALLR Allarity Therapeutics Inc	MRKR Marker Therapeutics Inc
Market & Valuation
Market Cap	$16M	$16M
Enterprise Value	$21M	$5M
Price	$0.99	$0.97
P/E Ratio	N/A	N/A
P/S Ratio	45.65x	6.93x
EV/Sales	61.03x	2.08x
EV/EBITDA	0.00x	0.00x
P/B Ratio	4.68x	1.44x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.53x	-0.50x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	3.16x
Revenue & Growth
Revenue (TTM)	$345K	$2M
Revenue Growth (YoY)	N/A	-46.2%
Forward Rev Growth	0.0%	375.8%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-771.9%	-284.3%
Net Margin (TTM)	-3575.1%	-236.6%
FCF Margin (TTM)	-3994.8%	-417.6%
Net Income (TTM)	$-12M	$-6M
FCF (TTM)	$-14M	$-10M
EPS (TTM)	-$0.78	-$0.27
ROE (TTM)	-15277.0%	-8086.0%
ROA (TTM)	-4650.0%	-6705.0%
ROIC (TTM)	-6256.0%	-8086.0%
Financial Health
Cash	$17M	$11M
Debt	$22M	$0
Net Cash/Debt	$-5M	$11M
Current Ratio (TTM)	1.11x	6.03x
Quick Ratio (TTM)	0.99x	5.60x
Debt/Equity (TTM)	6.30x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.60	1.59
52W Performance	-41.8%	-10.0%
YTD Performance	-13.2%	-36.9%
% from 52W High	-46.2%	-60.5%
% from 52W Low	28.6%	15.7%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.20x
FCF Yield (TTM)	-87.5%	-60.2%
Earnings Yield (TTM)	-78.3%	-34.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-3,994.8	-463.8
EV/GP/RG	N/A	N/A
Ticker research	View ALLR research	View MRKR research

Valuation

P/S Ratio

MRKR

6.93x

ALLR

45.65x

EV/FCF

ALLR

-1.53x

MRKR

-0.50x

Growth & revenue

Revenue Growth TTM

MRKR

-46.2%

Forward Revenue Growth

MRKR

375.8%

ALLR

0.0%

Profitability & performance

Gross Margin

ALLR

0.0%

MRKR

0.0%

ROE

MRKR

-8086.0%

ALLR

-15277.0%

FCF Yield %

MRKR

-60.2%

ALLR

-87.5%

52-Week Performance

MRKR

-10.0%

ALLR

-41.8%

Detailed metrics comparison

ALLR

Allarity Therapeutics Inc

MRKR

Marker Therapeutics Inc

Market Cap

ALLR$16M

MRKR$16M

Enterprise Value

ALLR$21M

MRKR$5M

Price

ALLR$0.99

MRKR$0.97

P/E Ratio

ALLRN/A

MRKRN/A

P/S Ratio

ALLR45.65x

MRKR6.93x

EV/Sales

ALLR61.03x

MRKR2.08x

EV/EBITDA

ALLR0.00x

MRKR0.00x

P/B Ratio

ALLR4.68x

MRKR1.44x

P/FCF Ratio

ALLRN/A

MRKRN/A

EV/FCF

ALLR-1.53x

MRKR-0.50x

PEG Ratio

ALLRN/A

MRKRN/A

Forward P/E (NTM)

ALLRN/A

MRKRN/A

Forward P/S (NTM)

ALLRN/A

MRKR3.16x

Revenue (TTM)

ALLR$345K

MRKR$2M

Revenue Growth (YoY)

ALLRN/A

MRKR-46.2%

Forward Rev Growth

ALLR0.0%

MRKR375.8%

Gross Margin (TTM)

ALLR0.0%

MRKR0.0%

Operating Margin (TTM)

ALLR0.0%

MRKR0.0%

EBITDA Margin (TTM)

ALLR-771.9%

MRKR-284.3%

Net Margin (TTM)

ALLR-3575.1%

MRKR-236.6%

FCF Margin (TTM)

ALLR-3994.8%

MRKR-417.6%

Net Income (TTM)

ALLR$-12M

MRKR$-6M

FCF (TTM)

ALLR$-14M

MRKR$-10M

EPS (TTM)

ALLR-$0.78

MRKR-$0.27

ROE (TTM)

ALLR-15277.0%

MRKR-8086.0%

ROA (TTM)

ALLR-4650.0%

MRKR-6705.0%

ROIC (TTM)

ALLR-6256.0%

MRKR-8086.0%

Cash

ALLR$17M

MRKR$11M

Debt

ALLR$22M

MRKR$0

Net Cash/Debt

ALLR$-5M

MRKR$11M

Current Ratio (TTM)

ALLR1.11x

MRKR6.03x

Quick Ratio (TTM)

ALLR0.99x

MRKR5.60x

Debt/Equity (TTM)

ALLR6.30x

MRKR0.00x

Debt/Assets (TTM)

ALLR0.0%

MRKR0.0%

Interest Coverage (TTM)

ALLRN/A

MRKRN/A

Net Debt/EBITDA (TTM)

ALLR0.00x

MRKR0.00x

Beta

ALLR0.60

MRKR1.59

52W Performance

ALLR-41.8%

MRKR-10.0%

YTD Performance

ALLR-13.2%

MRKR-36.9%

% from 52W High

ALLR-46.2%

MRKR-60.5%

% from 52W Low

ALLR28.6%

MRKR15.7%

Asset Turnover (TTM)

ALLR0.00x

MRKR0.20x

FCF Yield (TTM)

ALLR-87.5%

MRKR-60.2%

Earnings Yield (TTM)

ALLR-78.3%

MRKR-34.1%

Dividend Yield (TTM)

ALLRN/A

MRKRN/A

Rule of 40

ALLR-3,994.8

MRKR-463.8

EV/GP/RG

ALLRN/A

MRKRN/A

Ticker research

View ALLR research View MRKR research

Metric	ALLR Allarity Therapeutics Inc	MRKR Marker Therapeutics Inc
Market & Valuation
Market Cap	$16M	$16M
Enterprise Value	$21M	$5M
Price	$0.99	$0.97
P/E Ratio	N/A	N/A
P/S Ratio	45.65x	6.93x
EV/Sales	61.03x	2.08x
EV/EBITDA	0.00x	0.00x
P/B Ratio	4.68x	1.44x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.53x	-0.50x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	3.16x
Revenue & Growth
Revenue (TTM)	$345K	$2M
Revenue Growth (YoY)	N/A	-46.2%
Forward Rev Growth	0.0%	375.8%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-771.9%	-284.3%
Net Margin (TTM)	-3575.1%	-236.6%
FCF Margin (TTM)	-3994.8%	-417.6%
Net Income (TTM)	$-12M	$-6M
FCF (TTM)	$-14M	$-10M
EPS (TTM)	-$0.78	-$0.27
ROE (TTM)	-15277.0%	-8086.0%
ROA (TTM)	-4650.0%	-6705.0%
ROIC (TTM)	-6256.0%	-8086.0%
Financial Health
Cash	$17M	$11M
Debt	$22M	$0
Net Cash/Debt	$-5M	$11M
Current Ratio (TTM)	1.11x	6.03x
Quick Ratio (TTM)	0.99x	5.60x
Debt/Equity (TTM)	6.30x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.60	1.59
52W Performance	-41.8%	-10.0%
YTD Performance	-13.2%	-36.9%
% from 52W High	-46.2%	-60.5%
% from 52W Low	28.6%	15.7%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.20x
FCF Yield (TTM)	-87.5%	-60.2%
Earnings Yield (TTM)	-78.3%	-34.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-3,994.8	-463.8
EV/GP/RG	N/A	N/A
Ticker research	View ALLR research	View MRKR research